Live
Ecosystem 1 min read

BioInnovation Institute injects €1.3 million each into six startups tackling cancer, disease, pest control and decarbonisation

BioInnovation announced a startup programme or prize with a €1.3 million prize.

Nordic Startup News desk Based on reporting by EU-Startups Denmark · Single-source report
Read original reporting ↗
Image: EU-Startups Denmark

The BioInnovation Institute (BII) has announced a startup programme, injecting €1.3 million each into six startups focused on vital health and environmental challenges. This brings the total funding from BII to €1.8 million for each recipient.

The six startups—PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech, and Sagava—had initially secured €500,000 each from BII. Trine Bartholdy, Chief Business Officer at BII, praised the companies' progress from research to actionable solutions, further stating that continued funding will help accelerate their journey to market.

Reporting sources

Where this story comes from

1 reference

The facts above are grounded in the original reporting linked here. Open the publisher story for its complete context.

E EU-Startups Denmarkeu-startups.com
EU-Startups Denmark Open source

BioInnovation Institute injects €1.3 million each into six startups tackling cancer, disease, pest control and decarbonisation

The available publisher preview does not add detail beyond this brief. Open the original report for its full context.

Related coverage

This story in context

Read the closer connections in publication order. Separate background links appear below.

You are reading this story

Later coverage 1

  1. Shared organisation or participant

    BioInnovation Institute commits €8 million to six companies advancing health and sustainability

    The review identifies a shared named participant or subject. Publication order alone does not imply cause and effect.

    ArcticStartup
    Why linked? View evidence
    BioInnovation Institute commits €8 million to six companies advancing health and sustainabilityRecorded source excerpt · original wording
    BioInnovation Institute (BII) has committed a further €1.3 million each to six life science and climate tech companies—PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava—bringing its total investment in each to €1.8 million. The funding, provided through convertible loans, will support the companies as they advance their technologies toward commercialisation. The cohort spans [...]
    ArcticStartup ↗
    BioInnovation Institute commits €8 million to six companies advancing health and sustainabilityRecorded source excerpt · original wording
    BioInnovation Institute (BII) has committed a further €1.3 million each to six life science and climate tech companies—PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava—bringing its total investment in each to €1.8 million. The funding, provided through convertible loans, will support the compan...
    ArcticStartup ↗
    BioInnovation Institute injects €1.3 million each into six startups tackling cancer, disease, pest control and decarbonisationRecorded source excerpt · original wording
    Copenhagen-based BioInnovation Institute (BII) has awarded additional convertible loans of €1.3 million each to six of its portfolio companies, bringing the total capital each has received from the institute to €1.8 million. The six recipients — PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava — had each previously secured €500k from BII. “ The six companies have demonstrated strong potential an
    EU-Startups Denmark ↗
    BioInnovation Institute injects €1.3 million each into six startups tackling cancer, disease, pest control and decarbonisationRecorded source excerpt · original wording
    Copenhagen-based BioInnovation Institute (BII) has awarded additional convertible loans of €1.3 million each to six of its portfolio companies, bringing the total capital each has received from the institute to €1.8 million. The six recipients — PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava ...
    EU-Startups Denmark ↗
About this history review

The link graph’s cryptographic signature was verified. This proves integrity, not the truth of every claim or complete archive coverage.

Graph updated . Only articles retained in the public archive are included.

Open technical link data
Method & transparencyHow this brief was selected and checked
Editorial priority4 / 10

Tracked

Source coverageSingle-source report

Single-source report

ConfidenceLimited

44 / 100 · one source

Source basis

Grounded in the publisher material listed below.

Confirmation

No second independent source has been matched to this story yet.

Selection

Selected for publication after relevance, freshness and editorial-quality checks.

Selection factors

  • 1 independent source
  • 2 concrete event indicators
  • warning penalty: source_describes_ecosystem_data_not_funding_round, publisher_announced_startup_program

Source monitoring: 100% recent availability · No source-health warnings. The original publisher remains the authoritative source for the full report.